Influence of the fetal neuropeptide complex on changes in retinal light sensitivity over time in patients with primary open-angle glaucoma
DOI:
https://doi.org/10.31288/oftalmolzh201761619Keywords:
primary open-angle glaucoma, fetal neuropeptide complexAbstract
Purpose: To investigate the influence of a fetal neuropeptide complex on changes in retinal light sensitivity over time in patients with primary open-angle glaucoma (POAG).
Materials and Methods: The study involved 104 patients (192 eyes; age, 52 to 58 years) with medically controlled POAG and diagnosed with stage I, stage II or stage III glaucoma. In patients of the main group, the fetal neuropeptide complex (Cerebrocurine; Pat. of Ukraine №102,957 issued in 2015) was used as an adjunct to conventional hypotensive therapy. All patients underwent eye examination including visual acuity assessment, biomicroscopy, tonometry, and optical coherence tomography. Changes in retinal light sensitivity in patients with POAG were investigated through changes in mean deviation (MD) using automated static perimetry. In both groups, MD was assessed both before and after treatment.
Results: After treatment, the incidence of stabilized MD in patients in the main group was significantly higher than in controls (72.5% vs 45.6%, p < 0.05). The highest and the lowest indices of stabilized MD were seen in patients with glaucoma stage I and glaucoma stage III, respectively (84.8% and 51.8%, respectively).
Conclusion: In POAG patients, after the use of fetal neuropeptide complex as an adjunct to conventional treatment, the incidence of stabilized average deviation of retinal light sensitivity was statistically significantly (1.59 times) higher than after the use of conventional treatment only.
References
Alifanova TA, Poveschenko LP, Chuiko AL. [Disability following glaucoma: prevalence, causes and conditions for the development] In: [Filatov memorial lectures-2015. Proceeding of the Conference on the 140-th Anniversary of Acad. V.P. Filatov]. 2006 Mar 21-22; Odesa: Filatov Institute of Eye Diseases and Tissue Therapy; 2015. p.44-45. Russian.
Pasyechnikova NV, Rykov SA, Naumenko Liu, Kryzhanovskaia TV. [Prevention of Blindness and Visual Impairment in Ukraine: Current Status and Issues]. In: [Proceedings of the 12th Ukrainian National Congress of Ophthalmology]. 26-28 May, 2010, Odesa. p.303-4. Russian
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006 Mar;90(3):262-7.https://doi.org/10.1136/bjo.2005.081224
Quigley H. Worldwide epidemiology in glaucoma. European Glaucoma Society 9-th Congress 12-17 September 2010. Madrid, 2010. p. 42.
Vitovska O, Alifanova T, Poveshcenko J. Epidemiological aspects of primary disability caused by glaucoma in Ukraine. 7th World Glaucoma Congress, June 28 - July 1 2017, Helsinki. Abstract Book, 2017. p. 161 (P-WT-087).
Zavgorodniaia NG, Pasechnikova NV. [Primary glaucoma: A new look at an old problem]. Zaporizhzhia: Orbita-YUG; 2010. Russian
Kurysheva NI. [Glaucomatous optic neuropathy]. Moscow: MEDpressinform; 2006. Russian
Xu G, Weinreb RN, Leung CK. Retinal nerve fiber layer progression in glaucoma: a comparison between retinal nerve fiber layer thickness and retardance. Ophthalmology. 2013 Dec;120(12):2493-500.https://doi.org/10.1016/j.ophtha.2013.07.027
Sehi M, Zhang X, Greenfield DS, et al. Retinal Nerve Fiber Layer Atrophy is Associated with Visual Field Loss over Time in Glaucoma Suspect and Glaucomatous Eyes. Am J Ophthalmol. 2013 ; 155: 73-82.https://doi.org/10.1016/j.ajo.2012.07.005
Glinkich RE, Steinmann WC, Spaeth GL. Visual field change in low-tension glaucoma over a five-year follow-up. Ophthalmology. 1989 Mar;96(3):316-20.https://doi.org/10.1016/S0161-6420(89)33070-3
Nitta K, Sugiyama K, Higashide T, et al. Does the enlargement retinal nerve fiber layer defects related to disc hemorrhage or progressive visual field loss in normal-tension glaucoma. J. Glaucoma. 2011 Mar;20(3):189-95.https://doi.org/10.1097/IJG.0b013e3181e0799c
Wilson M.R. Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies. Trans Am Ophthalmol Soc. 2002;100:365-410
Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct;120(10):1268-79.https://doi.org/10.1001/archopht.120.10.1268
Volkov VV. [Open-angle glaucoma]. Moscow: Meditsinskoye informatsionnoye agentstvo LLC; 2008. Russian
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Н. В. Панченко, Е. Н. Гончарь, Г. С. Арустамова, А. С. Переяслова, Д. О. Приходько, М. В. Фрянцева
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
